Christopher Ray Aker - 09 Jan 2025 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker
Issuer symbol
RGLS
Transactions as of
09 Jan 2025
Net transactions value
+$113,360
Form type
4
Filing time
10 Jan 2025, 17:00:05 UTC
Previous filing
21 May 2024
Next filing
15 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Award $90,610 +66,625 +736% $1.36 75,681 09 Jan 2025 Direct F1
transaction RGLS Common Stock Award $22,750 +17,500 +23% $1.30 93,181 09 Jan 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 10, 2023, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vest upon achievement of a specified performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.
F2 On January 12, 2024, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vest upon achievement of a specified performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.